Document is current
Any future updates will be listed below
-
Authors
Dimitrov, Daniel
Türei, Dénes
Garrido-Rodriguez, Martin https://orcid.org/0000-0003-4125-5643
Burmedi, Paul L. https://orcid.org/0000-0001-8391-0031
Nagai, James S.
Boys, Charlotte
Ramirez Flores, Ricardo O. https://orcid.org/0000-0003-0087-371X
Kim, Hyojin
Szalai, Bence
Costa, Ivan G. https://orcid.org/0000-0003-2890-8697
Valdeolivas, Alberto https://orcid.org/0000-0001-5482-9023
Dugourd, Aurélien
Saez-Rodriguez, Julio https://orcid.org/0000-0002-8552-8976
- License Information
-
More Information
Article History
Received: 17 June 2021
Accepted: 17 May 2022
First Online: 9 June 2022
Competing interests
: J.S.R. has received funding from GSK and Sanofi and fees from Travere Therapeutics. A.V. is currently employed by F. Hoffmann-La Roche Ltd. The remaining authors declare no competing interests.
